During the past decade, Long Beach Memorial Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Long Beach Memorial Medical Center" are "Carcinoma, Renal Cell" (1 trials), "Coronavirus" (1 trials), "Early Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Long Beach Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "Long Beach Memorial Medical Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Giredestrant" (2 trials), "LHRH Agonist" (2 trials), "Atezolizumab" (1 trials), "Durvalumab" (1 trials) and "Endocrine Therapy of Physician's Choice" (1 trials). Other intervention names were less common.

The vast majority of trials in "Long Beach Memorial Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Long Beach Memorial Medical Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Long Beach Memorial Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Long Beach Memorial Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".